Who is the AVLS PRO Venous Registry? By Marlin Schul, MD, MBA, RVT, FAVLS, DABVLM
The AVLS PRO Venous Registry has grown exponentially. In 2021, we saw an increase in the number of patients and procedures. This growth is largely due to the compounding of data by existing AVLS providers. Currently nearly 200 providers are in our Registry. We need as many AVLS members contributing data as possible. The research generated from the Registry goes beyond interesting articles to read in our Journal. The data contributed by our members and the resulting research conducted will support and defend our field of practice against the continuing efforts of CMS and other payers to reduce payments – or even decide that there isn’t enough evidence supporting the health outcomes of treating pre-ulcer disease to justify any payments.
Total Records in the Database
Q1 2021
Q1 2022
Patients
180,573
276,611
Chemical Ablation
205,955
270,767
Conservative Therapy
9,271
187,616
Cyanoacrylate
4,097
7,741
Endovenous Laser Ablation
31,356
41,856
Mechanochemical Ablation
6
22
Radio Frequency Ablation
111,028
161,918
240,520
299,771
3,541
49,154
Sclerotherapy Surgery (Phlebectomy)
To learn more about becoming an AVLS PRO Venous Registry data provider, please contact Michael Thompson, Director of Research: mthompson@myavls.org
21
